Debt-to-equity of Ventyx Biosciences, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ventyx Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Ventyx Biosciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 9.6%, a 2.7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Ventyx Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 9.6% -0.27% -2.7% 30 Sep 2025
Q2 2025 9% -2.3% -20% 30 Jun 2025
Q1 2025 9.1% -1% -10% 31 Mar 2025
Q4 2024 8.8% -0.22% -2.4% 31 Dec 2024
Q3 2024 9.9% +2.8% +40% 30 Sep 2024
Q2 2024 11% +4.8% +74% 30 Jun 2024
Q1 2024 10% +3.4% +51% 31 Mar 2024
Q4 2023 9% +1.6% +21% 31 Dec 2023
Q3 2023 7% -0.44% -5.9% 30 Sep 2023
Q2 2023 6.5% -2.5% -28% 30 Jun 2023
Q1 2023 6.7% 31 Mar 2023
Q4 2022 7.4% 31 Dec 2022
Q3 2022 7.5% 30 Sep 2022
Q2 2022 8.9% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.